Westfield Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$335M Buy
364,579
+87,030
+31% +$88.2M 1.41% 13
2025
Q4
$298M Buy
277,549
+544
+0.2% +$520K 1.24% 14
2025
Q3
$211M Sell
277,005
-30,488
-10% -$22.7M 0.89% 21
2025
Q2
$240M Buy
307,493
+48,541
+19% +$37.7M 1.01% 19
2025
Q1
$214M Buy
258,952
+38,959
+18% +$32.4M 1.04% 17
2024
Q4
$170M Buy
219,993
+193,642
+735% +$160M 0.74% 27
2024
Q3
$23.3M Sell
26,351
-3,452
-12% -$3.1M 0.11% 178
2024
Q2
$27M Buy
29,803
+1,478
+5% +$1.18M 0.13% 178
2024
Q1
$22M Sell
28,325
-140,005
-83% -$99.6M 0.12% 181
2023
Q4
$98.1M Sell
168,330
-117,685
-41% -$68.7M 0.57% 49
2023
Q3
$154M Sell
286,015
-110,935
-28% -$57.2M 1.05% 16
2023
Q2
$186M Buy
396,950
+9,386
+2% +$3.94M 1.18% 15
2023
Q1
$133M Buy
387,564
+59,440
+18% +$20M 0.94% 20
2022
Q4
$120M Sell
328,124
-33,616
-9% -$11.9M 0.93% 21
2022
Q3
$117M Buy
361,740
+361,040
+51,577% +$114M 0.93% 21
2022
Q2
$227K Buy
+700
New +$210K ﹤0.01% 235
2018
Q2
Sell
-109,170
Closed -$8.45M 258
2018
Q1
$8.45M Sell
109,170
-923,681
-89% -$74.4M 0.07% 204
2017
Q4
$87.2M Sell
1,032,851
-373,662
-27% -$31.8M 0.67% 44
2017
Q3
$120M Buy
1,406,513
+78,333
+6% +$6.42M 0.92% 23
2017
Q2
$109M Buy
+1,328,180
New +$108M 0.93% 25
2013
Q3
Sell
-60,900
Closed -$2.99M 363
2013
Q2
$2.99M Buy
+60,900
New +$3.31M 0.02% 258

Other funds holding LLY

Westfield Capital Management's LLY Position: Q1 2026 in Review

Westfield Capital Management increased its Eli Lilly (LLY) stake by 31% in Q1 2026, buying an estimated $88.2M and bringing the position to 364,579 shares worth $335M. The position accounts for 1.41% of the portfolio, ranked #13.

Westfield Capital Management first reported a position in LLY in Q2 2013 and has held it in 21 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Westfield Capital Management held 364,579 shares of Eli Lilly worth $335M as of Q1 2026.
  • Westfield Capital Management bought 87,030 Eli Lilly shares in Q1 2026, an estimated $88.2M.
  • Eli Lilly made up 1.41% of Westfield Capital Management's portfolio in Q1 2026, its #13 holding.
  • Westfield Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 21 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.